62 participants
A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-15
- Start Date:
- 2014-05-31
- Completion:
- 2018-04-13
Conditions
- Colorectal Neoplasms
Interventions
- DRUG